Today's Science Pulse
UK-led study reveals hidden massive star clusters deep within nearby galaxies
Astronomers using the VLA and ALMA uncovered previously unseen giant star clusters embedded deep inside nearby galaxies. The findings show that young stellar activity drives the evolution of these galaxies, reshaping their interstellar environments. Multiple observations confirm the clusters act as hidden “ring factories” of star formation.
Also developing:
By the numbers: Foundation Alloy raises $22M Series A
Simulating Quantum Materials with Arnab Banerjee
In this episode, host Sebastian Hassinger talks with experimental physicist Arnab Banerjee about using quantum computers to simulate real quantum materials. Banerjee explains how his team used IBM’s 153‑qubit Heron processor to reproduce neutron‑scattering data from the magnetic crystal KCuF₃, achieving a quantitative match that validates quantum simulation as a reliable benchmark. He also discusses his work on quantum spin liquids, the role of neutron scattering in revealing spin dynamics, and why topological states could enable error‑resilient qubits. Throughout, Banerjee emphasizes a pragmatic, platform‑agnostic view of quantum computing, drawing on experience with superconducting gates, neutral‑atom arrays, and quantum annealing.
NASA’s Artemis II Astronauts Celebrate Epic Lunar Flyby with Stunning New Images
NASA’s Artemis II crew completed a historic lunar flyby, becoming the farthest humans from Earth and capturing unprecedented images of the Moon’s far side. The mission also featured the first Earthrise and total solar eclipse observed by astronauts since Apollo, along...
Streaming Giants Broadcast Artemis II Lunar Flyby, Marking New TV Era
NASA partnered with Netflix, Amazon Prime Video, Apple TV+, Hulu, HBO Max, Roku and its own NASA+ service to livestream the Artemis II lunar flyby on April 6. The multi‑platform rollout follows an 18.1 million‑viewer broadcast of the launch and signals a...
University of Arizona Launches $12 Million Rapamycin Clinical Trial
The University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to boost resilience and immune function in adults aged 65 and older. The six‑year study, funded by a $12 million...
From Giants' Shoulders to Moon's New Foundations
Your whole life you hear about the shoulders of giants. Then one day you wake up and find you're the shoulders. Four broad new sets of shoulders just orbited the Moon. Imagine how many more will stand upon them. nasa canadianspaceagency #Artemis
HexemBio Raises $10.4M for a Stem Cell Rejuvenation Therapy
HexemBio announced a $10.4 million seed round led by Draper Associates to develop a blood‑stem‑cell rejuvenation therapy built on its Synthetic Human Yolk Sac platform. The technology temporarily places a patient’s own haematopoietic cells into a recreated embryonic niche, then returns...
Trump's $73B GovTech Budget Cuts Target NIH, NSF and Security Programs
President Donald Trump unveiled a FY2027 discretionary budget that trims $73 billion from domestic programs, including a $5 billion reduction to the National Institutes of Health and a 55% cut to the National Science Foundation. The plan reshapes federal research, health tech...
The Future of Cell & Gene Therapy: Key Trends to Watch
Cell and gene therapy is transitioning from ex vivo manufacturing toward in vivo delivery, driven by advances in vector engineering and lipid‑nanoparticle platforms. Major pharma players have launched billion‑dollar acquisitions to secure in vivo CAR‑T and RNA technologies, while the stem‑cell market is...
Is ‘Lab-Grown’ Meat Actually Safe?
In 2023 the U.S. Food and Drug Administration cleared the first lab‑grown chicken for sale after it passed safety assessments. Cultivated meat is produced by culturing animal cells in bioreactors, yielding a product nutritionally close to conventional meat but with...
An Upper Bound on Effective Quantum Computation?
A recent PNAS paper argues that a fundamental limit exists on how many qubits can be meaningfully entangled, estimating an upper bound of roughly 1,000 logical qubits. The limit stems from a proposed discretization of space, which restricts the range...
Cell‑Replacement Trials Edge Closer to Type 1 Diabetes Cure, Researchers Say
Late‑stage cell‑replacement trials are expected to read out within the next few years, bringing a functional cure for type 1 diabetes into view. Researchers cite stem‑cell transplants and immune‑shielding strategies as the next frontier, while patients and advocates stress the life‑changing...
Stipple Launches with $100M for Novel Oncology Targets
Stipple, a new biotech focused on oncology, announced a $100 million Series A financing round to pursue novel, historically undruggable cancer targets. The round was led by top‑tier venture firms and includes strategic commitments from several large pharmaceutical partners. Stipple’s founding team...
April 7, 1991: Compton Gamma Ray Observatory Is Deployed
NASA’s Compton Gamma Ray Observatory (CGRO) was deployed from Space Shuttle Atlantis on April 7, 1991, marking the launch of the agency’s third Great Observatory focused on gamma‑ray astronomy. A thermal‑blanket snag that prevented the high‑gain antenna from opening required an unscheduled...
Optimization of Brain-Permeable SGK1 Inhibitors for Neurodegenerative Diseases
Jiangsu and Shanghai Hengrui Pharmaceuticals have patented selective Nav1.8 sodium‑channel blockers that alleviate inflammatory and neuropathic pain in rodent studies and are slated for IND‑enabling toxicology this year, aiming for Phase I trials in 2027. Parallel research highlights chronic inflammation’s role...
Dectisomes Show Potent Activity Against High-Priority Fungal Pathogens
Jiangsu and Shanghai Hengrui patented selective Nav1.8 blockers that show potent analgesic effects with minimal off‑target activity. New research links chronic inflammation in the bone‑marrow niche to epigenetic reprogramming of hematopoietic stem cells, suggesting early‑intervention strategies for leukemia prevention. Infinimmune...
Suzhou Spring-Sea Bio-Pharmaceuticals Identifies New GLP-1R Agonists
Suzhou Spring‑Sea Bio‑Pharmaceuticals announced the discovery of a novel series of glucagon‑like peptide‑1 receptor (GLP‑1R) agonists that demonstrate high potency and prolonged half‑life in pre‑clinical models. The compounds show superior glucose‑lowering efficacy compared with existing market leaders and exhibit favorable...
Acadia Pharmaceuticals Presents GPR88 Agonists
Researchers at Jiangsu and Shanghai Hengrui have patented Nav1.8 blockers that deliver strong analgesic effects while sparing off‑target channels, opening a new avenue for chronic pain therapy. Parallel studies reveal that chronic inflammation can reprogram hematopoietic stem cells, driving early...
Orexin OX2 Receptor Agonists Disclosed in Vertex Pharmaceuticals Patent
Vertex Pharmaceuticals has filed a patent covering a new series of orexin OX2‑receptor agonists, marking the company’s first public foray into sleep‑modulating therapeutics. The disclosed molecules feature distinct heterocyclic cores and enhanced blood‑brain barrier penetration, aiming for improved potency and...
Holiday Notice
Jiangsu and Shanghai Hengrui Pharmaceuticals have patented selective Nav1.8 sodium‑channel blockers that demonstrate potent analgesic effects with minimal off‑target activity, opening a new avenue for chronic pain treatment. Parallel research highlights how chronic inflammation reshapes the bone‑marrow microenvironment, driving hematopoietic...
Chengdu Kanghong Pharmaceutical Patents New Lipoprotein(a)-Lowering Agents
Researchers at Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that relieve neuropathic and inflammatory pain in rodents without impairing motor function, with filings in China and the United States and IND‑enabling work slated for later this year....
Next-Generation Anti-CD30 ADC Outperforms Brentuximab Vedotin
Biopharma X unveiled a next‑generation anti‑CD30 antibody‑drug conjugate that demonstrated superior efficacy and tolerability compared with the established therapy brentuximab vedotin. In preclinical models, the ADC achieved deeper tumor regressions and a broader therapeutic window, driven by an optimized linker...
Nrf2 Activator Counteracts Atopic Dermatitis Pathology
Researchers have identified a novel Nrf2 activator that mitigates key pathological features of atopic dermatitis in preclinical studies. The compound suppresses oxidative stress and downregulates pro‑inflammatory cytokines, leading to restored skin barrier integrity in murine models. Data presented at the...
New LRH-1 Antagonists Exhibit Antitumor Activity in Prostate Cancer Models
Researchers have identified a new class of liver receptor homolog‑1 (LRH‑1) antagonists that demonstrate potent antitumor activity in preclinical prostate cancer models. In mouse xenografts, oral administration of the compounds reduced tumor volume by up to 65% without notable adverse...
NASA’s New Moon Base Project Requires Operational Technology Systems in Space, but They Are Vulnerable.
NASA Administrator Jared Isaacman announced a $20 billion Moon‑base program, shifting from a lunar‑orbit station to a surface settlement. The plan, timed against China’s 2030 lunar landing goal, includes robotic landers, drones, and a future nuclear power plant. Experts warn the...
Emory University Synthesizes New Prostaglandin EP2 Receptor Antagonists
Researchers at Jiangsu and Shanghai Hengrui have patented selective Nav1.8 sodium‑channel blockers that deliver potent analgesic effects with minimal off‑target activity, opening a new avenue for chronic pain therapy. Parallel studies highlight how chronic inflammatory signals remodel hematopoietic stem cells,...
Cantor, Dedekind, and the Rivalry Over Infinity
Amazing Math Story – Cantor and Dedekind and Infinity Did I already mention that @QuantaMagazine has the best science and math podcast out there? Here’s an amazing story I heard there recently. Cantor is famous for inventing Set Theory and for the...
Metasurface Enables Supersensitive, Superfast Thermal-Based Photodetector
Researchers at Duke University have created a metasurface‑enhanced pyroelectric photodetector that operates at a record‑breaking 3‑dB bandwidth of 2.8 GHz, equivalent to a 125 picosecond rise time. The device uses an ultra‑thin array of silver nanocubes atop a gold mirror, separated by...
Higher Protein Intake Reverses Sarcopenia in Elderly Women
As a medical school professor, the protein recommendation I was taught -- 0.8 g/kg body weight -- is actively harming older adults. New data proves it. A 2025 Frontiers in Nutrition trial randomized 126 elderly women with sarcopenia into two groups...
Scientists Develop Gene-Edited Wheat that Can Make Toasted Bread Less Carcinogenic
Scientists at Rothamsted Research have used CRISPR to edit wheat genes responsible for free asparagine, the precursor of the carcinogen acrylamide formed during toasting. Field trials showed up to a 93% reduction in asparagine without any yield loss, and bread...
CRISPR-Edited Wheat Leads to Reduced Acrylamide Without Yield Loss
Scientists at Rothamsted Research have used CRISPR/Cas9 to create wheat lines with dramatically lower free asparagine, achieving reductions of up to 93% while maintaining normal yield and protein levels. Field trials showed that bread and biscuits made from the edited...
University of Arizona Launches $12 Million Rapamycin Clinical Trial
University of Arizona’s R. Ken Coit College of Pharmacy is launching a double‑blind, randomized Phase 3 clinical trial to test low‑dose rapamycin’s ability to improve resilience and immune function in adults 65 and older. The $12 million study is fully funded by...
Sanofi Immune Drug Hopeful Posts Mixed Results in Mid-Stage Tests
Sanofi reported mixed Phase 2 results for its bispecific antibody lunsekig. The drug achieved its primary and key secondary endpoints in moderate‑to‑severe asthma and chronic rhinitis with nasal polyps, showing reduced exacerbations, improved lung function and smaller polyps. Conversely, lunsekig failed...
Ultra‑processed Foods Hijack Brain Reward Like Cocaine
As a medical school professor, I have to be blunt: ultra-processed food is not just unhealthy. It is neurologically addictive. A February 2026 review in Pharmacological Research analyzed neuroimaging and molecular data and concluded: -- Ultra-processed foods activate the same dopamine reward...
Biogen Collaborates with Alloy Therapeutics to Advance Antisense Therapeutics
Biogen has signed a collaboration and license agreement with Alloy Therapeutics to use the company’s AntiClastic antisense oligonucleotide (ASO) platform on multiple undisclosed targets. The deal provides Alloy with an upfront cash payment, additional milestone fees and tiered royalties on...
In-Space Manufacturing’s Billion-Dollar Problem: Great Science, No Business Model
In‑space manufacturing has demonstrated scientific promise for decades, yet no product has achieved commercial viability. The primary obstacle remains the economics of launching, operating, and returning payloads, which far exceed the market value of niche items like ZBLAN fiber or...
The Vagus Nerve: Your Body’s Hidden Lifespan Connector
What if one small nerve quietly connects your brain to your heart, your gut, your immune system — and even how long you live? That was the question I brought to Dr. Elisabetta Burchi, a clinical psychiatrist, neuroscience researcher, and Head...
UF/IFAS Breeding Disease-Resistant Lettuce
University of Florida’s Institute of Food and Agricultural Sciences is close to releasing disease‑resistant lettuce varieties, backed by a $500,000 USDA‑NIFA grant. Researchers are leveraging a rare Macedonian lettuce that naturally resists bacterial leaf spot and have bred hundreds of...
After Artemis: What a Sustained Lunar Presence Actually Means for Deep Space Exploration Economics
The Artemis program, now entering its crewed Artemis II flight, aims to transition from short‑term visits to a permanent lunar presence, with landings slated from 2028 and a base camp envisioned for the 2030s. Total program costs through 2025 are projected...
Exercise Cuts Visceral Fat, Boosts Insulin Sensitivity in NIDDM
Mobilization of Visceral Adipose Tissue Related to the Improvement in Insulin Sensitivity in Response to Physical Training in NIDDM: Effects of branched-chain amino acid supplements 🔘"Patients who exercised increased their VO2 peak by 41% and their insulin sensitivity by 46%... 🔘with a...
India Leverages Thorium to Outlast Global Uranium Limits
India has ~2% of global uranium but ~25% of thorium. What was once a weakness became a strategy. In the 1950s, Homi Bhabha designed a 3-stage program: • Uranium → Plutonium • Plutonium → Breeds more fuel • Thorium → U-233 India holds ~846,000 tonnes of...
Bringing Air Quality Data Closer to People
Rainmatter Foundation has unveiled an open, pan‑India air‑quality platform that aggregates data from government sensors, satellites, and crowd‑sourced monitors. The service delivers neighbourhood‑level PM2.5 and AQI readings, filling a long‑standing gap where official data is either inaccessible or too coarse....
Sarcopenia Doubles Death and Disability Risk in Seniors
As a medical school professor, I can tell you the most dangerous disease you have never heard of is sarcopenia -- and a massive new meta-analysis just proved it. A 2026 Frontiers in Nutrition review of thousands of community-dwelling older adults...
NASA’s Artemis Era May Finally Solve Three Major Moon Mysteries
NASA’s Artemis program, now in its crewed Artemis II flight, is laying the groundwork for a sustained lunar presence that could finally answer three long‑standing moon mysteries. Upcoming Artemis IV (targeted for 2028) will deliver the Lunar Environment Monitoring Station, creating the...
Gene Therapy Poised to Redefine Obesity Treatment Landscape
1/GLP-1 obesity and weight-loss drugs - such as $NVO Ozempic & Wegovy and $LLY Zepbound & Mounjaro have long become a household name - making Obesity the fastest growing market in the BioTech and Pharma ecosystem and generating unprecedented revenues....
Stay Grounded Amid Rapid Bioinformatics Advances
🧵Bioinformatics evolves fast. New tech. New data. New analysis. But here's how to stay grounded and not get overwhelmed: https://t.co/VdWFpeE93W
Your Vitamin D Levels in Midlife Could Shape Your Brain Decades Later
A 16‑year longitudinal study of 793 middle‑aged adults found that higher vitamin D levels in their 30s‑40s were associated with lower tau protein accumulation later, a biomarker linked to Alzheimer’s disease. Participants with vitamin D above 30 ng/mL showed reduced tau...
Neutral Atoms Become Second‑largest Qubit Platform by Company Count
neutral atoms are now officially the second most competitive qubit platform out there in terms of numbers of companies… with at least one more company in stealth. https://t.co/XoL1yY1JY2
Science Provides Incremental Evidence, Not Absolute Truth
Scientific findings are often presented as conclusive "when in reality they represent incremental evidence within a larger, uncertain body of work. A single study cannot establish truth; at best, it shifts probabilities" ht @ProfNoahGian https://t.co/V4FSnNTHOi https://t.co/kdOnLWm9xl
Four‑Month MDF Cuts NAFLD Liver Fat by 24%
"The 4-month intervention with this MDF was effective in reducing IHTC in patients with NAFLD by an absolute reduction of −5.89% and a relative reduction of −24.30% after adjusting for weight loss. Such effect was partly mediated by altered composition...
Orion Streams Stunning Moon‑orbit Photos on Return
Amazing photos and videos continue to come back from the Orion spacecraft as it rounds the Moon and heads home. https://t.co/uLvZnKyfjq